|
Prostatic Diseases
|
D011469 |
[Pathological processes involving the PROSTATE or its component tissues.
] |
|
p18 protein, Leucophaea maderae
|
C442323 |
|
|
3-cyclohexylalanyl-3-nitrotyrosyl-homocyclohexylalanyl-proline
|
C442324 |
|
|
3-cyclohexylalanyl-4-nitrophenylalanyl-3-nitrotyrosyl-proline
|
C442325 |
|
|
dicyclodextrinyl ditelluride
|
C442326 |
|
|
Mig-2 protein, C elegans
|
C442327 |
|
|
lmd protein, Drosophila
|
C442328 |
|
|
Prostaglandins F
|
D011460 |
[(9 alpha,11 alpha,13E,15S)-9,11,15-Trihydroxyprost-13-en-1-oic acid (PGF(1 alpha)); (5Z,9 alpha,11,alpha,13E,15S)-9,11,15-trihydroxyprosta-5,13-dien-1-oic acid (PGF(2 alpha)); (5Z,9 alpha,11 alpha,13E,15S,17Z)-9,11,15-trihydroxyprosta-5,13,17-trien-1-oic acid (PGF(3 alpha)). A family of prostaglandins that includes three of the six naturally occurring prostaglandins. All naturally occurring PGF have an alpha configuration at the 9-carbon position. They stimulate uterine and bronchial smooth muscle and are often used as oxytocics.
] |
|
OOC-5 protein, C elegans
|
C442329 |
|
|
Prostaglandins F, Synthetic
|
D011461 |
[Analogs or derivatives of prostaglandins F that do not occur naturally in the body. They do not include the product of the chemical synthesis of hormonal PGF.
] |
|
Prostaglandins G
|
D011462 |
[A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. Most frequently encountered member of this group is the prostaglandin G2.
] |
|
CCL16 protein, human
|
C481939 |
|
|
Prostaglandins H
|
D011463 |
[A group of physiologically active prostaglandin endoperoxides. They are precursors in the biosynthesis of prostaglandins and thromboxanes. The most frequently encountered member of this group is the prostaglandin H2.
] |
|
Epoprostenol
|
D011464 |
[A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY).
] |
|
Prostaglandins, Synthetic
|
D011465 |
[Compounds obtained by chemical synthesis that are analogs or derivatives of naturally occurring prostaglandins and that have similar activity.
] |
|
6-deoxyacetoxyatalantin acetate
|
C456960 |
|
|
4-(4-chlorophenylazo)-3-methyl-1-(2-hydroxy-3-morphilinopropan-1-yl)-2-pyrazolin-5-one
|
C456961 |
|
|
2,3-difluorobenzonitrile
|
C456962 |
|
|
saikosaponin t
|
C456963 |
|
|
AF-5 compound
|
C481920 |
|
